Complete Clinical Responses to Neoadjuvant Chemotherapy for Uterine Serous Carcinoma
- 1 April 1999
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 73 (1) , 140-144
- https://doi.org/10.1006/gyno.1998.5303
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- CA 125 may not reflect disease status in patients with uterine serous carcinomaCancer, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Neoadjuvant Chemotherapy in Uterine Papillary Serous CarcinomaGynecologic Oncology, 1996
- Early Pathologic Stage Clear Cell Carcinoma and Uterine Papillary Serous Carcinoma of the EndometriumInternational Journal of Gynecological Pathology, 1995
- Uterine Papillary Serous Carcinoma: Patterns of Metastatic SpreadGynecologic Oncology, 1994
- Intravenous Cisplatin, Doxorubicin, and Cyclophosphamide in the Treatment of Uterine Papillary Serous Carcinoma (UPSC)Gynecologic Oncology, 1993
- Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)Gynecologic Oncology, 1992
- Neoadjuvant chemotherapy in stage X ovarian carcinomaGynecologic Oncology, 1990
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982